聯交所公開譴責中生北控生物科技(08247.HK)兩名前董事
聯交所對中生北控生物科技(08247.HK)前副主席兼執行董事陳錦添及前執行董事陳建華發出董事不適合性聲明,同時亦公開譴責二人,認為二人不適合擔任該公司或其任何附屬公司的董事或高級管理職務。
聯交所表示,上市科曾就有關於中生北控生物科技出售一家附屬公司前,該附屬公司若干貸款獲得償付0事宜向上述人士作出查詢,相關董事為當時涉及還款討論的主要董事,但二人一直沒有回覆上市科的調查函。
GEM 上市委員會裁定相關董事因沒有配合上市科的調查,違反此前作出的《董事聲明及承諾》,因而構成違反《GEM上市規則》,又指即使二人已辭任該公司董事,亦仍然有責任向聯交所提供合理要求的資料,認為二人違反其《承諾》的情況嚴重,因此決定施加有關制裁。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.